Table 2.
Continuation of Temporary Medications after Hospital Discharge
| Antipsychotic cohort | Benzodiazepine cohort | Gastric acid suppressant cohort | Respiratory inhaler cohort | |
|---|---|---|---|---|
| (n = 899,917) | (n = 719,449) | (n = 556,323) | (n = 667,318) | |
| Prescription within 7 days of discharge | 12,209 (1.4 %) | 23,806 (3.3 %) | 34,140 (6.1 %) | 14,469 (2.2 %) |
| Prescription within 30 days of discharge | 15,242 (1.7 %) | 36,282 (5.0 %) | 43,690 (7.9 %) | 18,994 (2.8 %) |
| Chronic use over 1 year* | 5101 (0.6 %) | 5352 (0.7 %) | 14,925 (2.7 %) | 3880 (0.6 %) |
| 1-year cost of medication ($CAD)† | 3,942,634 | 632,475 | 10,876,911 | 3,241,023 |
| Total cost ($CAD)† | 18,693,043 |
*Patients dispensed medications within 7 days were followed for a maximum of 425 days to identify chronic use, defined as an additional claim for the same medication within 60 days of the 1-year anniversary date (i.e. from 305 to 425 days post-index date)
†Reflects total actual cost of the selected medications prescribed to individuals in the year following hospital discharge
Abbreviations: CAD = Canadian dollar